What is CG Oncology's change in accrued liabilities?

CG Oncology (CGON) reported change in accrued liabilities of $1.61M in Q1 2026.

How has CG Oncology's change in accrued liabilities changed year-over-year?

CG Oncology's change in accrued liabilities increased by 92.2% year-over-year, from $836K to $1.61M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

CG Oncology CGON Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Gilead SciencesGILD

-$702M-188%

ImmunityBio, Inc.IBRX

$3.14M+124%

Cogent Biosciences, Inc.COGT

-$10.2M-17.8%

Summit TherapeuticsSMMT

$12.22M+658%

ExelixisEXEL

$4.04M-12.2%

BiogenBIIB

-$243.2M+19.1%

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.39B+206%

Enterprise value$5.36B+212%

P/S1,062.4×-1,596×

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's change in accrued liabilities?: CG Oncology (CGON) reported change in accrued liabilities of $1.61M in Q1 2026.
How has CG Oncology's change in accrued liabilities changed year-over-year?: CG Oncology's change in accrued liabilities increased by 92.2% year-over-year, from $836K to $1.61M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.